Award

NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

NHS ENGLAND

This public procurement record has 1 release in its history.

Award

24 Mar 2023 at 11:46

Award Notice
Summary of the contracting process

The NHS England has recently awarded a National Framework Agreement for the supply of Adalimumab Injection with a total value of £264,003,000. The procurement stage was an open procedure above the threshold, with a tender period ending on 28th November 2022. The contract period covers 1st April 2023 to 28th February 2026. The industry category is Pharmaceutical products, and the contract was awarded on 3rd March 2023.

This tender presents significant business opportunities for suppliers in the pharmaceutical industry who specialize in the supply of Adalimumab Injection. Small and medium-sized enterprises (SMEs) can benefit from this framework agreement, as it involves multiple regions across the UK. Businesses with experience in large-scale pharmaceutical supply contracts are well-suited to compete in this procurement process, paving the way for sustainable business growth and expansion.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

Notice Description

Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£264,003,000 £100M-£1B
Lots Value
Not specified
Awards Value
£264,003,228 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
24 Mar 20232 years ago
Submission Deadline
28 Nov 2022Expired
Future Notice Date
Not specified
Award Date
3 Mar 20232 years ago
Contract Period
31 Mar 2023 - 28 Feb 2026 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Katie Noonan
Contact Email
katie.noonan@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Post Town
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
6
Supplier Names

ABBVIE

AMGEN

BIOGEN

CELLTRION HEALTHCARE UNITED KINGDOM

FRESENIUS KABI

SANDOZ

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0-2023-03-24T11:46:28Z",
    "date": "2023-03-24T11:46:28Z",
    "ocid": "ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CF-1377900D0O000000rwimUAA",
        "title": "NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023",
        "description": "Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "WA7 2ES"
                    },
                    {
                        "region": "England",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 264003000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure (above threshold)",
        "tenderPeriod": {
            "endDate": "2022-11-28T13:00:00Z"
        },
        "contractPeriod": {
            "startDate": "2023-04-01T00:00:00+01:00",
            "endDate": "2026-02-28T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-156205",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "2nd Floor Rutland House",
                "locality": "Runcorn",
                "postalCode": "WA7 2ES",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Katie Noonan",
                "email": "katie.noonan@nhs.net"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-238636",
            "name": "Amgen Ltd",
            "identifier": {
                "legalName": "Amgen Ltd"
            },
            "address": {
                "streetAddress": "216 Science Park Milton Road, Cambridge, CB4 0WA"
            },
            "details": {
                "scale": "large"
            },
            "roles": [
                "supplier"
            ]
        },
        {
            "id": "GB-CFS-239914",
            "name": "Sandoz Ltd",
            "identifier": {
                "legalName": "Sandoz Ltd"
            },
            "address": {
                "streetAddress": "Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., GU15 3YL"
            },
            "details": {
                "scale": "sme"
            },
            "roles": [
                "supplier"
            ]
        },
        {
            "id": "GB-CFS-238726",
            "name": "Biogen",
            "identifier": {
                "legalName": "Biogen"
            },
            "address": {
                "streetAddress": "Innovation House 70 Norden Road, Maidenhead Berkshire, SL6 4AY"
            },
            "details": {
                "scale": "large"
            },
            "roles": [
                "supplier"
            ]
        },
        {
            "id": "GB-CFS-238640",
            "name": "Abbvie Ltd",
            "identifier": {
                "legalName": "Abbvie Ltd"
            },
            "address": {
                "streetAddress": "Abbvie House, Vanwall Business Park, Vanwall Road,, Maidenhead, Berks., SL6 4UB"
            },
            "details": {
                "scale": "large"
            },
            "roles": [
                "supplier"
            ]
        },
        {
            "id": "GB-CFS-239915",
            "name": "Fresenius Kabi Limited",
            "identifier": {
                "legalName": "Fresenius Kabi Limited"
            },
            "address": {
                "streetAddress": "Cestrian Court, Eastgate Way, Manor Park,, Runcorn, Cheshire,, WA7 1NT"
            },
            "details": {
                "scale": "large"
            },
            "roles": [
                "supplier"
            ]
        },
        {
            "id": "GB-CFS-238633",
            "name": "Celltrion Healthcare United Kingdom Limited",
            "identifier": {
                "legalName": "Celltrion Healthcare United Kingdom Limited"
            },
            "address": {
                "streetAddress": "The Switch ,1-7 The Grove,, Slough, SL1 1QP"
            },
            "details": {
                "scale": "large"
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-156205",
        "name": "NHS England"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0-1",
            "status": "active",
            "date": "2023-03-03T00:00:00Z",
            "datePublished": "2023-03-24T11:46:28Z",
            "value": {
                "amount": 264003228,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-238636",
                    "name": "Amgen Ltd"
                },
                {
                    "id": "GB-CFS-239914",
                    "name": "Sandoz Ltd"
                },
                {
                    "id": "GB-CFS-238726",
                    "name": "Biogen"
                },
                {
                    "id": "GB-CFS-238640",
                    "name": "Abbvie Ltd"
                },
                {
                    "id": "GB-CFS-239915",
                    "name": "Fresenius Kabi Limited"
                },
                {
                    "id": "GB-CFS-238633",
                    "name": "Celltrion Healthcare United Kingdom Limited"
                }
            ],
            "contractPeriod": {
                "startDate": "2023-04-01T00:00:00+01:00",
                "endDate": "2026-02-28T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660",
                    "datePublished": "2023-03-24T11:46:28Z",
                    "format": "text/html",
                    "language": "en"
                },
                {
                    "id": "2",
                    "description": "5660_02 Transparency Award Schedule",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/28fe1d39-9c1b-4293-9b1f-9ec053766193",
                    "format": "application/pdf"
                },
                {
                    "id": "3",
                    "description": "5660_03 Transparency Award Schedule",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/16647a0d-d52c-4e25-89a2-88ccd1f97e7e",
                    "format": "application/pdf"
                },
                {
                    "id": "4",
                    "description": "5660_04 Transparency Award Schedule",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/2dc44a21-0812-4592-944e-7dd9285f07b0",
                    "format": "application/pdf"
                },
                {
                    "id": "5",
                    "description": "030223-2022 FTS Opportunity National Framework Agreement for Adalimumab Injection 1 April 2023",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/c9c6a1c5-0c14-4c52-9d09-b40887c92179",
                    "format": "application/pdf"
                },
                {
                    "id": "6",
                    "description": "5660_01 Transparency Award Schedule",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/2d836161-4648-499c-9ea5-2ca8cb1ef685",
                    "format": "application/pdf"
                },
                {
                    "id": "7",
                    "description": "Parties Appointed to the framework CM-PHR-22-5660",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/29ee5fb1-a16a-4c69-9084-4b70c029fc65",
                    "format": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"
                },
                {
                    "id": "8",
                    "description": "03 Framework Agreement and Terms and Conditions - CM_PHR_22_5660 - National Framework Agreement for Adalimumab Injection April 2023",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/7e2ab6fb-bde7-4919-a5b6-7c5b4ef397f7",
                    "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document"
                }
            ]
        }
    ]
}